MITA News

  • MITA News

    Gail Rodriguez, executive director of the Medical Imaging & Technology Alliance (MITA), suggested that, apart from Hughes’ study, there’s ample anecdotal evidence pointing to physicians’ support of advanced imaging for a very simple reason: steady technological improvement. “When I started in imaging 20 some-odd years ago, the sensitivity and specificity were acceptable; they were OK,” said Rodriguez. “Today we are looking at much higher accuracy quantifying things like tumor volumes. I really think that sort of precision is part of why these physicians have become so much more comfortable with advanced imaging over the years.”

  • MITA News

    The Medical Imaging & Technology Alliance (MITA), Advanced Medical Technology Association (AdvaMed) and the Medical Device Manufacturers Association (MDMA) are applauding the legislation. The organizations believe that the medical technology industry is “an important engine for economic growth in the United States” since it employs over 400,000 workers globally and generates about $25 billion in payroll.

  • MITA News

    The Protect Medical Innovation Act (HR 160) is sponsored by Reps. Erik Paulsen (R-MN) and Ron Kind (D-WI) and was introduced with 254 original co-sponsors. The proposal has already received support from the Medical Imaging and Technology Alliance (MITA), the Advanced Medical Technology Association (AdvaMed), and the Medical Device Manufacturers Association (MDMA).

  • MITA News

    The global medical device market in 2014 was a challenging one, but agile companies found opportunities for growth.

  • MITA News

    XR-29, MITA’s latest dose related standard, may require one in three CT scanners in the U.S. to be replaced if the facility wishes to receive full CMS reimbursement on select procedures.

  • MITA News

    Bucking a negative assessment from its own appointed review panel, the U.S. Centers for Medicare and Medicaid Services (CMS) on Monday approved CT lung cancer screening for Medicare recipients, saying the evidence is sufficient to justify screening high-risk individuals until the age of 74 years.

  • MITA News

    As technology advances, the imaging industry likewise develops safeguards to protect patients and promote the highest quality care. We do this in part by creating and implementing standards. The National Electrical Manufacturers Association (NEMA) and Medical Imaging & Technology Alliance (MITA) have taken the lead to create rigorous standards and encourage their adoption across the industry.

  • MITA News

    According to The National Breast Cancer Foundation, 98 percent of breast cancer patients survive – if detection occurs early. Since the late 1960s, traditional mammography has been used widely for breast cancer detection. The future of breast cancer care, however, lies in even earlier detection and individually tailored diagnosis and treatment, and imaging manufacturers are developing technologies that make these possible.

  • MITA News
    10.09.14

    The Dose Debate

    During the last 5 years, a spotlight has been cast on the issue of radiation dose management, fueled by public concern in the aftermath of two incidents of excessive radiation administered in California in 2009.

  • MITA News

    The Medical Imaging & Technology Alliance (MITA) today said a new analysis published in the Annals of Internal Medicine confirms the value of low-dose computed tomography (LDCT) lung imaging for high-risk Medicare-eligible patients. “These findings provide even more direct evidence of the benefits of low-dose CT imaging for detecting lung cancer in Medicare beneficiaries at high risk for this deadly disease,” said Gail Rodriguez, executive director of MITA.